发布求助
文献互助 智能选刊 最新文献

Japanese Journal of Pharmacoepidemiology\/yakuzai Ekigaku最新文献

筛选
英文 中文
Medication Changes During Hospitalization and Readmission Among Older Patients with Heart Failure in Japan 日本老年心力衰竭患者住院和再入院期间的药物变化
Japanese Journal of Pharmacoepidemiology\/yakuzai Ekigaku Pub Date : 2021-06-20 DOI: 10.3820/jjpe.26.e1
D. Abe, M. Oba, Y. Murakami, Shinji Hisatake, T. Ikeda
{"title":"Medication Changes During Hospitalization and Readmission Among Older Patients with Heart Failure in Japan","authors":"D. Abe, M. Oba, Y. Murakami, Shinji Hisatake, T. Ikeda","doi":"10.3820/jjpe.26.e1","DOIUrl":"https://doi.org/10.3820/jjpe.26.e1","url":null,"abstract":"Objective ：The number of heart failure（HF）patients is increasing in Japan as its population continues to age, but little is known about current medication strategies. We investigated the relationship between medication changes during hospitalization and the readmission rate among older Japanese patients with new-onset HF. Design ：Retrospective cohort study. Methods ：We analyzed medical record data from Toho University Medical Center Omori Hospital between March 2004 and April 2018. Initial admissions for new-onset HF in patients aged B 75 years were examined ／ （n＝329). The class Ⅰ recommended medications stipulated in the JCS 2017／JHFS 2017 guidelines were used as the target medications for this study. Patients with dose titrations or additions of the target medications during hospitalization（dose titrations or additions group）were compared with patients without these changes（the other group). The primary outcome was readmission due to HF within one year of discharge. A hazard ratio, adjusted for potential confounders, was estimated using a Cox proportional hazards model. Results ：There were 231 patients in dose titrations or additions group and 98 patients in the other group. The one-year readmission rate was 26.5％ in dose titrations or additions group and 31.8％ in the other group. The adjusted hazard ratio of medication changes for readmission was 0.82（95％ confidence interval, 0.51-1.33, P＝0.415), but was not statistically significant. Conclusion ：The older HF patients in dose titrations or additions group showed a reduced risk of readmission, but lacked significance due to low statistical power.","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83065959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
2．Response to COVID-19 from a Social Welfare Policy Perspective 2．社会福利政策视角下的COVID-19应对
Japanese Journal of Pharmacoepidemiology\/yakuzai Ekigaku Pub Date : 2021-06-20 DOI: 10.3820/JJPE.26.63
I. Wada
{"title":"2．Response to COVID-19 from a Social Welfare Policy Perspective","authors":"I. Wada","doi":"10.3820/JJPE.26.63","DOIUrl":"https://doi.org/10.3820/JJPE.26.63","url":null,"abstract":"","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"253 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77141763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3．Value Assessment of Vaccines and Drugs： Learnings from COVID-19 Pandemic 3.疫苗和药物的价值评估:从COVID-19大流行中吸取的教训
Japanese Journal of Pharmacoepidemiology\/yakuzai Ekigaku Pub Date : 2021-06-20 DOI: 10.3820/JJPE.26.71
Y. Aitoku
{"title":"3．Value Assessment of Vaccines and Drugs： Learnings from COVID-19 Pandemic","authors":"Y. Aitoku","doi":"10.3820/JJPE.26.71","DOIUrl":"https://doi.org/10.3820/JJPE.26.71","url":null,"abstract":"","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"238 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83474080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5．Confronting COVID-19： Current Issues of SARS-CoV-2 Therapeutic Drug/Vaccine Development 5．面对COVID-19: SARS-CoV-2治疗药物/疫苗开发的当前问题
Japanese Journal of Pharmacoepidemiology\/yakuzai Ekigaku Pub Date : 2021-06-20 DOI: 10.3820/JJPE.26.91
W. Sugiura
{"title":"5．Confronting COVID-19： Current Issues of SARS-CoV-2 Therapeutic Drug/Vaccine Development","authors":"W. Sugiura","doi":"10.3820/JJPE.26.91","DOIUrl":"https://doi.org/10.3820/JJPE.26.91","url":null,"abstract":"","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73430830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
1．COVID-19 and HTA
Japanese Journal of Pharmacoepidemiology\/yakuzai Ekigaku Pub Date : 2021-06-20 DOI: 10.3820/JJPE.26.56
A. Igarashi
{"title":"1．COVID-19 and HTA","authors":"A. Igarashi","doi":"10.3820/JJPE.26.56","DOIUrl":"https://doi.org/10.3820/JJPE.26.56","url":null,"abstract":"","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75225634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of Epidemiological Methods for Studying the Infection Risk in Rheumatoid Arthritis with Methotrexate Combined Biologicals using Propensity Scores 使用倾向评分研究类风湿关节炎甲氨蝶呤联合生物制剂感染风险的流行病学方法的验证
Japanese Journal of Pharmacoepidemiology\/yakuzai Ekigaku Pub Date : 2021-06-20 DOI: 10.3820/jjpe.26.e3
Takuma Koinuma, M. Akazawa
{"title":"Validation of Epidemiological Methods for Studying the Infection Risk in Rheumatoid Arthritis with Methotrexate Combined Biologicals using Propensity Scores","authors":"Takuma Koinuma, M. Akazawa","doi":"10.3820/jjpe.26.e3","DOIUrl":"https://doi.org/10.3820/jjpe.26.e3","url":null,"abstract":"Probability Weighting Estimator（IPW）and Augmented Inverse Probability Weighting Estimator（AIPW） analyses. Results ：The Odds Ratios（OR）estimated by each method using the time axis of the elapsed time, the prescription number, and the administration time were 1.48（95％CI 0.71-3.11), 1.60（95％CI 0.72-3.55), and 1.04（95％CI 0.58-1.86), respectively. We performed PS weighting, of each Average Treatment Effect obtained from IPW, and the AIPW were estimated to be 0.31％（95％CI −0.91-1.53）and 0.29％（95％CI −0.91-1.49), respectively, and the average treatment effect on the treated was estimated to be 0.10％ （95％CI −1.11-1.32). We support the findings of a previous study which showed that the combination of biologicals was not statistically associated with increased infection risk. Conclusion ：This study suggests that estimators from different perspectives might be obtained by using some epidemiological methods. Therefore, our results could contribute to the establishment of an improved methodology.","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83195250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
演者紹介 演者绍介
Japanese Journal of Pharmacoepidemiology\/yakuzai Ekigaku Pub Date : 2021-01-01 DOI: 10.3820/jjpe.26.s94
{"title":"演者紹介","authors":"","doi":"10.3820/jjpe.26.s94","DOIUrl":"https://doi.org/10.3820/jjpe.26.s94","url":null,"abstract":"","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"120 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75831376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SGLT2 阻害薬の開始タイミングがその後の腎機能に及ぼす影響の評価：電子カルテ情報を用いた解析 评价SGLT2抑制剂起始时间对后续肾功能的影响:利用电子病历信息进行分析
Japanese Journal of Pharmacoepidemiology\/yakuzai Ekigaku Pub Date : 2021-01-01 DOI: 10.3820/jjpe.26.s152
正人 竹内, 浩司 川上
{"title":"SGLT2 阻害薬の開始タイミングがその後の腎機能に及ぼす影響の評価：電子カルテ情報を用いた解析","authors":"正人 竹内, 浩司 川上","doi":"10.3820/jjpe.26.s152","DOIUrl":"https://doi.org/10.3820/jjpe.26.s152","url":null,"abstract":"","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"81 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76277776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ポスター演題3 海报演题3
Japanese Journal of Pharmacoepidemiology\/yakuzai Ekigaku Pub Date : 2021-01-01 DOI: 10.3820/jjpe.26.s160
{"title":"ポスター演題3","authors":"","doi":"10.3820/jjpe.26.s160","DOIUrl":"https://doi.org/10.3820/jjpe.26.s160","url":null,"abstract":"","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"42 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76329800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
抗菌薬・抗真菌薬の使用とスティーヴンス・ジョンソン症候群及び中毒性表皮壊死症のリスク 抗菌药和抗真菌药的使用和斯蒂芬·约翰逊综合征以及中毒性表皮坏死的风险
Japanese Journal of Pharmacoepidemiology\/yakuzai Ekigaku Pub Date : 2021-01-01 DOI: 10.3820/jjpe.26.s131
俊貴 深澤, 尚巳 漆原, 勇人 高橋, 浩司 川上
{"title":"抗菌薬・抗真菌薬の使用とスティーヴンス・ジョンソン症候群及び中毒性表皮壊死症のリスク","authors":"俊貴 深澤, 尚巳 漆原, 勇人 高橋, 浩司 川上","doi":"10.3820/jjpe.26.s131","DOIUrl":"https://doi.org/10.3820/jjpe.26.s131","url":null,"abstract":"","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87704542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信